Antiviral Drugs in Influenza.
Magdalena Świerczyńska1, Dagmara M Mirowska-Guzel1, Edyta Pindelska2
1Centre for Preclinical Research and Technology CePT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland.
Summary
Baloxavir marboxil offers a new mechanism for treating influenza (flu) and shows comparable safety and effectiveness to existing antiviral drugs. Combination therapy for flu may yield promising future results.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Influenza (flu) poses significant health and economic burdens globally.
- Current antiviral therapies for influenza have limitations, necessitating new treatment options.
- Baloxavir marboxil represents a novel antiviral agent with a distinct mechanism of action.
Purpose of the Study:
- To review and compare all available antiviral drugs for influenza A and B.
- To evaluate the efficacy, safety, mechanism of action, and administration of these antivirals.
- To assess the potential of baloxavir marboxil in influenza treatment.
Main Methods:
- Comprehensive literature review of anti-influenza medications.
- Comparative analysis of drug mechanisms, administration, indications, target populations, effectiveness, and safety.
- Evaluation of baloxavir marboxil's profile against existing therapies.
Main Results:
- Baloxavir marboxil demonstrates a safety and efficacy profile comparable to established influenza treatments.
- The study provides an overview of current antiviral options for influenza A and B.
- No single therapy currently offers completely satisfactory results for all influenza cases.
Conclusions:
- Baloxavir marboxil is a promising addition to the influenza antiviral armamentarium.
- Further research into combination therapy for influenza is warranted and may offer improved outcomes.
- Continued development of effective influenza treatments remains a critical public health goal.
Keywords:
amantadinebaloxavir marboxilinfluenza treatmentlaninamivirneuraminidase inhibitorsoseltamivirperamivirzanamivirMore Related Videos
Related Concept Videos
02:28Leaky Scanning
5.3K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K
01:29Subviral Agents
155
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
155
01:10Retrovirus Life Cycles
47.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.2K
01:16Drugs Used in Upper Respiratory Disorders: Overview
389
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
389
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K